JAGX 8-K 2026-06-22

Jaguar Health, Inc. (JAGX) 8-K dated 2026-06-22 — accession 0001193125-26-276845. This URL is the filing, not the JAGX hub.

Jaguar Health, Inc. (JAGX) is a biotechnology company listed on NASDAQ.

Jaguar Health, Inc. filed a 8-K on 2026-06-22. Accession 0001193125-26-276845.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.

Not investment advice. The JAGX SEC hub lists recent forms. The stock page is the research view.